Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 39 holding rows worth $1,276,035,000.

Accession
0001546927-14-000108
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 39 entries on the cover page, a total value of $1,276,035,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,276,035,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,250,000$233,763,000thousands by filing dateput
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,650,000$87,186,000thousands by filing date
WELLPOINT INC94973V107COM800,000$79,640,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock1,700,000$72,777,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock1,100,000$63,712,000thousands by filing date
CONMED CORP COM207410101Stock1,385,000$60,178,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK1,250,000$48,962,000thousands by filing date
VOLCANO CORPORATION928645100COM2,450,000$48,289,000thousands by filing date
HCA Healthcare Inc40412C101COM800,000$42,000,000thousands by filing date
Mallinckrodt PlcG5785G107SHS650,000$41,216,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock1,202,000$39,173,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW375,000$36,829,000thousands by filing date
MASIMO CORP COM574795100Stock1,275,000$34,820,000thousands by filing date
HOLOGIC INC436440101COM1,500,000$32,250,000thousands by filing date
UNIVERSAL AMERN CORP NEW91338E101COM4,178,259$29,540,000thousands by filing date
UnitedHealth Group Inc91324P102COM300,000$24,597,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM3,000,000$24,180,000thousands by filing date
HILL ROM HLDGS INC431475102COM600,000$23,124,000thousands by filing date
Abbott Laboratories002824100COM600,000$23,106,000thousands by filing date
HUMANA INC COM444859102Stock200,000$22,544,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK1,250,000$21,300,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW11,000,000$19,910,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM750,000$19,755,000thousands by filing date
BLUEBIRD BIO INC09609G100COM706,900$16,075,000thousands by filing date
FURIEX PHARMACEUTICALS36106P101COM150,000$13,050,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO613,655$13,022,000thousands by filing date
MYLAN INC628530107COM250,000$12,207,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK820,535$10,454,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK2,250,000$10,192,000thousands by filing date
GERON CORP374163103COM4,700,000$9,823,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM300,000$9,450,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365A101COM2,000,000$9,160,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM908,100$9,027,000thousands by filing date
TARGACEPT INC87611R306COM1,560,000$7,410,000thousands by filing date
SEQUENOM INC COM NEW817337405COM2,911,520$7,133,000thousands by filing date
BIOLASE INC090911108COMMON STOCK2,715,119$6,543,000thousands by filing date
ANGIODYNAMICS INC03475V101COM411,930$6,488,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM400,000$4,660,000thousands by filing date
CROSS CTRY HEALTHCARE INC227483104COM308,542$2,490,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001546927-14-000108this filing2014-05-15acceptance time not in the bulk data set